Earlier this year, in an effort to alleviate unnecessary regulatory burdens, President Trump issued two executive orders, Executive Order 13771, Reducing Regulatory and Controlling Regulatory Costs and Executive Order 13777, Enforcing the Regulatory Reform Agenda. On September 8, 2017, FDA published several notices in the Federal Register, to implement these orders, soliciting comments from
Latest Post
More Posts
Follow the Money: FDA Issues New Procedures for Evaluating Financial Ties Between Application Sponsors and Clinical Investigators
NIH and FDA Announce Release of Draft Clinical Trial Protocol Template; Call for Comments by April 17, 2016
It’s Settled … At Least Somewhat: Settlement of the First Amendment Case Amarin Pharma v. FDA
Subscribe: Subscribe via RSS
Blogs
Firm/Org